Advertisement

Topics

CENTRE D’IMMUNOLOGIE PIERRE FABRE Company Profile

08:18 EST 24th November 2017 | BioPortfolio

Located in France, close to the biotech heart of Geneva, the CIPF is a part of Pierre FABRE Laboratories (over 9000 people in France and overseas).
Created in 1990, our Research Centre - 100 collaborators - is dedicated to the discovery, development and production of antibody-based molecules to treat cancer. Combining multiple research expertise in experimental oncology, genetic engineering, molecular and cellular biology, and biochemistry, together with a sound know-how in antibody humanization, cellular imaging, molecular modelling and bioinformatics.

In addition, the CIPF possesses an Industrial Pilot plant dedicated to process development and production of recombinant molecules of therapeutic interest.

Location

5,avenue Napoléon III
St Julien en
Genevois Cedex,
BP 497, 74164
France

Contact

Phone: 33 4.50.35.35.55
Fax: 33 4.50.35.35.90
Email: alain.dorison@pierre-fabre.com


News Articles [325 Associated News Articles listed on BioPortfolio]

Pierre Fabre to commercialize Aprotecol in Italy

Spain-based Noventure and the Italian subsidiary of France’s Pierre Fabre have entered into an agreement…

Institut Curie, Pierre Fabre Partner on immuno-oncology

Institut Curie and the IRPF (Institut de Recherche Pierre Fabre) will collaborate on new therapeutic strategies to advance cancer treatment for patients. The objective of this novel partnership is to ...

Pierre Fabre secures Italian distribution rights for Noventure's Aprotecol

Noventure has allied with Pierre Fabre Pharma Italy in a partnership which will see the latter distribute the Spanish start-up’s paediatric intestinal treatment Aprotecol in Italy. read more

Cellectar and Pierre Fabre extend PDC deal

Institut Curie, Pierre Fabre partner to develop cancer immunotherapies

Cellectar Biosciences and Pierre Fabre Extend Collaboration for Development of New Phospholipid Drug Conjugates

MADISON, Wis. and CASTRES, France, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, clinical stage biotechnology company (the “company”), toge...

Noventure And Pierre Fabre Enter Into An Agreement To Commercialise Aprotecol In Italy

  Life Sciences Jobs   ...

Cellectar Biosciences And Pierre Fabre Extend Collaboration For Development Of New Phospholipid Drug Conjugates

  Life Sciences Jobs   ...

PubMed Articles [365 Associated PubMed Articles listed on BioPortfolio]

The Pierre Robin Mandible is Hypoplastic and Morphologically Abnormal.

For Pierre Robin sequence (PRS) patients, there is incomplete characterization of 3D differences and effects of mandibular distraction osteogenesis (MDO) on the mandible compared to normal controls.

Ameloblastic Fibro-Odontoma of the Maxilla in a Pierre-Robin Sequence Patient.

Pierre Robin sequence (PRS) is a rare disorder classically observed as a triad of features including micrognathia, glossoptosis, and upper airway obstruction. It is associated with a syndrome in about...

Postoperative Respiratory Complications After Cleft Palate Closure in Patients With Pierre Robin Sequence: Operative Considerations.

In cleft palate surgery, there is currently no consensus on the management of patients with Pierre Robin Sequence (PRS). The authors aimed to evaluate the treatment strategy of cleft palate in our cen...

Safety and Efficiency in a Canadian Outpatient Gynaecological Surgical Centre.

This study sought to describe safety and efficiency outcomes for patients undergoing procedures at the Women's Health Centre, an outpatient gynaecological surgical centre in Saskatoon, SK.

Differences in optimality index between planned place of birth in a birth centre and alternative planned places of birth, a nationwide prospective cohort study in The Netherlands: results of the Dutch Birth Centre Study.

To compare the Optimality Index of planned birth in a birth centre with planned birth in a hospital and planned home birth for low-risk term pregnant women who start labour under the responsibility of...

Clinical Trials [881 Associated Clinical Trials listed on BioPortfolio]

Impact of Phonatory and Facial Morphology Disorders, on the Quality of Life of Adolescents With Pierre Robin Sequence

The study team has made the hypothesis that the intensity of the phonatory disorders (rhinolalia), and of the maxillo-mandibular growth anomalies (facial morphology), may have negative eff...

Early Treatment Outcomes in Pierre-Robin-Like Phenotype

In a longitudinal cohort study, we want to assess the effect of the pre-epiglottic baton plate, the main treatment approach currently used in Germany for Pierre-Robin-Like phenotype, on up...

A Multi-Centre Clinical Study in Chronic Spinal Cord Injury Patients

To establish a solid foundation, e.g. network and a coordinating centre for testing new SCI therapies in forthcoming randomized controlled multi-centre clinical trials following internatio...

Evaluating an Intervention to Increase Use of Call Centre Support for Self-managed Medical Abortion

Self-management of medical abortion (MA) pills purchased from pharmacies is considered to be one of the reasons behind falling morbidity and mortality from unsafe abortion in recent years....

Comparing Nutritional Status of In-centre Nocturnal Hemodialysis Patients to Conventional Hemodialysis Patients

Although hemodialysis is life-saving, unfortunately, people on dialysis often have declining health, quality of life as well as poor nutritional status. Hemodialysis patients must follow a...

Companies [370 Associated Companies listed on BioPortfolio]

Pierre Fabre SA

Pierre Fabre group, France's second biggest independent pharmaceutical laboratory, achieved a turnover of 1.75 billion euros in 2008. Approximatively 10,000 people including 1,400 in the research ...

CENTRE D’IMMUNOLOGIE PIERRE FABRE

Located in France, close to the biotech heart of Geneva, the CIPF is a part of Pierre FABRE Laboratories (over 9000 people in France and overseas). Created in 1990, our Research Centre - 100 collabor...

Groupe Pierre Fabre

The Pierre Fabre Group, the second largest independent French pharmaceutical company and leader in the field of in-pharmacy dermo-cosmetics, employs about 10,000 people worldwide, including 1,400 ...

Laboratoires Pierre Fabre S A

Nil

PIERRE GUERIN S.A.S

Supporting Food and Health industriesA specialist in stainless steel products and a designer and manufacturer of process vessels integrating sophisticated and innovative features in agitation, mixing,...

More Information about "CENTRE D’IMMUNOLOGIE PIERRE FABRE" on BioPortfolio

We have published hundreds of CENTRE D’IMMUNOLOGIE PIERRE FABRE news stories on BioPortfolio along with dozens of CENTRE D’IMMUNOLOGIE PIERRE FABRE Clinical Trials and PubMed Articles about CENTRE D’IMMUNOLOGIE PIERRE FABRE for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CENTRE D’IMMUNOLOGIE PIERRE FABRE Companies in our database. You can also find out about relevant CENTRE D’IMMUNOLOGIE PIERRE FABRE Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record